{{Rsnum
|rsid=645088
|Gene=ME2
|Chromosome=18
|position=50930533
|Orientation=plus
|GMAF=0.3209
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ME2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 37.2 | 49.6 | 13.3
| HCB | 42.3 | 40.1 | 17.5
| JPT | 33.6 | 43.4 | 23.0
| YRI | 70.1 | 25.9 | 4.1
| ASW | 56.1 | 36.8 | 7.0
| CHB | 42.3 | 40.1 | 17.5
| CHD | 42.2 | 46.8 | 11.0
| GIH | 60.4 | 34.7 | 5.0
| LWK | 54.5 | 42.7 | 2.7
| MEX | 56.9 | 36.2 | 6.9
| MKK | 60.9 | 32.7 | 6.4
| TSI | 36.3 | 49.0 | 14.7
| HapMapRevision=28
}}

[http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1196416] May Underlie Susceptibility to Adolescent-Onset Idiopathic Generalized Epilepsy

{{omim
|id=154270
|desc=MALIC ENZYME 2; ME2
|rsnum=645088
}}

{{omim
|id=154270
|rsnum=645088
|variant=0001
}}

{{PMID Auto
|PMID=15532013
|Title=Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}